feed,title,long_url,short_url
Benzinga,Achieve Life Sciences Initiates Pivotal Trial Of Cytisinicline For Smoking Cessation,https://benzinga.com/general/biotech/22/01/25212041/achieve-life-sciences-initiates-pivotal-trial-of-cytisinicline-for-smoking-cessation,https://bit.ly/3rOoCyP
Benzinga,"Capricor Therapeutics, Nippon Shinyaku Ink US Pact For Duchenne Muscular Dystrophy Candidate",https://benzinga.com/general/biotech/22/01/25211638/capricor-therapeutics-nippon-shinyaku-ink-us-pact-for-duchenne-muscular-dystrophy-candidate,https://bit.ly/3KFfK77
Benzinga,Checkpoint Therapeutics' Cosibelimab Posts 47.4% ORR In Skin Cancer Patients,https://benzinga.com/general/biotech/22/01/25210440/checkpoint-therapeutics-cosibelimab-posts-47-4-orr-in-skin-cancer-patients,https://bit.ly/3AvFLRw
